Evidence map›Paper›PMID 21733846›Full record

ArticleThe Journal of biological chemistry2011

WNK2 kinase is a novel regulator of essential neuronal cation-chloride cotransporters.

Jesse Rinehart, Norma Vázquez, Kristopher T Kahle, Caleb A Hodson, Aaron M Ring, Erol E Gulcicek, Angeliki Louvi, Norma A Bobadilla, Gerardo Gamba, Richard P Lifton

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 96 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. RMD open · 2025
    Article
  7. Article
  8. Article
  9. PAX6-WNK2 Axis Governs Corneal Epithelial Homeostasis.Investigative ophthalmology & visual science · 2024
    Article
  10. Article
  11. Article
  12. Germline mutations inJournal of medical genetics · 2023
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Jesse RinehartDepartment of Genetics, Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
Norma Vázquez
Kristopher T Kahle
Caleb A Hodson
Aaron M Ring
Erol E Gulcicek
Angeliki Louvi
Norma A Bobadilla
Gerardo Gamba
Richard P Lifton
Howard Hughes Medical Institute · USUniversidad Nacional Autónoma de México · MXYale University · USHarvard University · US

Funding

Yale/NIDA Neuroproteomics Research CenterP30DA018343 · NIDA · YALE UNIVERSITY · PI Kenneth Robert WILLIAMS · 2004 to 2026
$37.1M
Investigation of Electrolyte Homeostasis via Quantitative ProteomicsK01DK089006 · NIDDK · YALE UNIVERSITY · PI RINEHART, JESSE · 2010 to 2014
$772k
Howard Hughes Medical InstituteNIDA NIH HHS 2P30DA018343NIDA NIH HHS P30 DA018343
6 · The paper itself

Abstract

NKCC1 and KCC2, related cation-chloride cotransporters (CCC), regulate cell volume and γ-aminobutyric acid (GABA)-ergic neurotranmission by modulating the intracellular concentration of chloride [Cl(-)]. These CCCs are oppositely regulated by serine-threonine phosphorylation, which activates NKCC1 but inhibits KCC2. The kinase(s) that performs this function in the nervous system are not known with certainty. WNK1 and WNK4, members of the WNK (with no lysine [K]) kinase family, either directly or via the downstream SPAK/OSR1 Ste20-type kinases, regulate the furosemide-sensitive NKCC2 and the thiazide-sensitive NCC, kidney-specific CCCs. What role the novel WNK2 kinase plays in this regulatory cascade, if any, is unknown. Here, we show that WNK2, unlike other WNKs, is not expressed in kidney; rather, it is a neuron-enriched kinase primarily expressed in neocortical pyramidal cells, thalamic relay cells, and cerebellar granule and Purkinje cells in both the developing and adult brain. Bumetanide-sensitive and Cl(-)-dependent (86)Rb(+) uptake assays in Xenopus laevis oocytes revealed that WNK2 promotes Cl(-) accumulation by reciprocally activating NKCC1 and inhibiting KCC2 in a kinase-dependent manner, effectively bypassing normal tonicity requirements for cotransporter regulation. TiO(2) enrichment and tandem mass spectrometry studies demonstrate WNK2 forms a protein complex in the mammalian brain with SPAK, a known phosphoregulator of NKCC1. In this complex, SPAK is phosphorylated at Ser-383, a consensus WNK recognition site. These findings suggest a role for WNK2 in the regulation of CCCs in the mammalian brain, with implications for both cell volume regulation and/or GABAergic signaling.

Indexed as

AnimalsCell SizeHumansMultiprotein ComplexesNerve Tissue ProteinsOocytesProtein Serine-Threonine KinasesPurkinje CellsPyramidal CellsSodium-Potassium-Chloride SymportersXenopus laevisMultiprotein ComplexesNerve Tissue ProteinsProtein Serine-Threonine KinasesSodium-Potassium-Chloride SymportersWNK2 protein, human

Identifiers

PMID21733846
PMCPMC3191056
OpenAlexW1988457198

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.